The RIGHT Act amends section 2791(b) of the Public Health Service Act to add a new, single statutory definition of “short‑term limited duration insurance.” Under the new paragraph, a short‑term plan must have an expiration date less than 12 months from the contract’s original effective date and may not run for more than three years in total when renewals or extensions are counted.
This is a narrow, technical change: the bill does not add coverage requirements, consumer protections, or changes to guaranteed‑issue or essential health benefit rules. Its practical effect will be to fix a federal legal definition that insurers and regulators use to classify short‑term plans — a classification with downstream consequences for market availability, state regulation, and enrollee protections.
At a Glance
What It Does
The bill inserts paragraph (6) into 42 U.S.C. §300gg–91(b), defining “short‑term limited duration insurance” as a contract with an initial expiration date under 12 months and a maximum aggregate duration of three years when renewals/extensions are included. It is a definition-only amendment; it does not itself mandate benefits, pricing rules, or enrollment requirements.
Who It Affects
It directly affects health insurance issuers, brokers and producers that offer or market short‑term plans, and federal and state regulators who rely on the PHSA definition to classify products. Indirectly, it affects consumers who choose short‑term policies and issuers selling ACA‑compliant coverage because product classification influences market behavior and oversight.
Why It Matters
Classification determines which federal rules apply (and which do not). By codifying these term and renewal thresholds in statute, the bill reduces regulatory uncertainty about whether a plan qualifies as short‑term and locks in a temporal boundary that will shape how insurers design contracts and how regulators enforce consumer protections and market rules.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill does one thing and does it plainly: it adds a new paragraph to the statutory definitions in the Public Health Service Act that describes what counts as “short‑term limited duration insurance.” Two numeric limits control the label. First, any contract that wants the short‑term label must specify an expiration date that falls short of 12 months from the contract’s original effective date.
Second, the statute caps the total time a consumer can be on successive short‑term contracts at three years, and it expressly says that renewals and extensions count toward that cap.
Because the change is a definition only, it does not itself change coverage content or require issuers to cover particular benefits. It also does not alter statutory guarantees tied to other parts of title XXVII (for example, essential health benefits or guaranteed‑issue rules) — but labeling matters.
Whether a product is treated as a short‑term plan determines what federal requirements do or do not apply, and that classification feeds into how states regulate product design, marketing, and consumer disclosures.Operationally, insurers will need to structure contract language and renewal mechanics to meet the two numeric limits. Regulators and overseers will need to track aggregate duration across renewals and flag arrangements (automatic re‑issuance, sequential short contracts, or rollovers) that attempt to evade the three‑year cap.
Because the statute focuses on dates and duration, enforcement will turn on contract terms, renewal records, and how extensions are implemented in practice.Finally, the statute is silent on many front‑line consumer protections. It does not change underwriting rules, preexisting‑condition exclusions, marketing disclosure standards, or issuer solvency requirements.
That silence means this definitional change will shift marketplace incentives without itself creating new protections for people who buy short‑term coverage.
The Five Things You Need to Know
The bill adds paragraph (6) to 42 U.S.C. §300gg–91(b) to define “short‑term limited duration insurance.”, A qualifying short‑term contract must specify an expiration date less than 12 months after the contract’s original effective date.
The statute bars aggregate duration of short‑term coverage from exceeding three years when renewals or extensions are counted.
The amendment is definition‑only: it does not impose benefit mandates, guaranteed‑issue standards, or other consumer protections within the text of the bill.
Enforcement and compliance will depend on contract language and renewal tracking because the term’s boundaries are defined by specified expiration dates and cumulative duration.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name, “Removing Insurance Gaps for Health Treatment (RIGHT) Act of 2025.” This is a conventional heading with no substantive legal effect; it serves to identify the enactment in statutory and administrative references.
Amendment to PHSA section 2791(b)
Directs a single textual amendment to title XXVII by adding a new paragraph (6) to the statutory definitions. That insertion is the operative change: it creates a statutory label that agencies, courts, insurers, and states will use to decide whether a product is ‘‘short‑term limited duration insurance.’
Numeric limits on term and total duration
Subparagraph (A) requires each contract to show an expiration date under 12 months after the original effective date — a bright‑line initial term ceiling. Subparagraph (B) imposes an aggregate cap of three years on the total duration of short‑term coverage, explicitly including renewals and extensions. Practically, that means issuers can issue sub‑12‑month contracts and permit renewals, but they must stop offering continuous short‑term coverage once a consumer has exceeded three years in the aggregate.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Issuers specializing in short‑term products — The statutory definition gives those issuers a clearer federal benchmark for product design and marketing, reducing regulatory ambiguity about whether certain contract structures qualify as short‑term. This can lower compliance costs tied to uncertainty.
- Consumers seeking low‑cost, temporary coverage — People who need temporary bridging coverage (for example, between jobs or waiting for employer coverage) may find a more stable market for short‑term products if insurers rely on the defined framework to offer consistent contracts.
- Brokers and producers of short‑term plans — With a codified definition, brokers can better advise clients on plan duration limits and design renewal strategies that comply with federal definition thresholds.
- State regulators that prefer uniform federal definitions — States that rely on federal classification for reporting or market oversight gain a consistent statutory standard to reference when evaluating filings or marketing materials.
Who Bears the Cost
- ACA‑compliant insurers — If the definitional clarity encourages growth in short‑term sales, comprehensive plans may face adverse selection and pricing pressure as healthier enrollees migrate to cheaper short‑term options.
- Consumers with chronic conditions — Because the bill does not attach protections (like guaranteed issue or EHBs) to short‑term plans, people who purchase them risk gaps in coverage or medical bills if their conditions are excluded by underwriting.
- State regulators and enforcement agencies — Tracking cumulative durations across renewals will require systems and resources; states that actively police evasion (sequencing contracts to exceed the 3‑year cap) may incur administrative and litigation costs.
- Federal regulators (HHS/CMS) — Agencies may face disputes over interpretation (for example, what counts as an extension), and they may need to issue guidance or rulemaking to operationalize the new statutory text.
Key Issues
The Core Tension
The central dilemma is access versus adequacy: the bill locks in a clear federal boundary to make temporary, lower‑cost coverage more reliably available — which helps people needing short‑term gaps — but it does so without adding protections against underwriting exclusions or coverage gaps, potentially undermining the financial and risk‑pool protections of comprehensive plans.
The bill’s narrowness is both its strength and its weakness. By limiting the change to a definitional provision, Congress avoids rewriting benefit rules or underwriting law, but that very narrowness leaves many consequential questions unresolved.
The statute sets two temporal thresholds but does not define terms that will matter in enforcement: what precisely constitutes an “extension” or a de facto renewal, how to treat automatic re‑issuance, and how to aggregate coverage when consumers switch issuers. Those gaps invite litigation and administrative guidance.
Equally important, the bill does not address substantive consumer protections. Codifying a temporal boundary can encourage a larger market for short‑term products, but it does not mitigate the principal market risk: short‑term plans typically do not include essential health benefits, often permit medical underwriting, and can exclude preexisting conditions.
Expanding the availability of such plans without parallel disclosure, solvency, or transition‑of‑care safeguards risks shifting costs to patients and to the broader insured pool over time. Implementing the statute will therefore force regulators to choose between strict oversight (which raises administrative burdens) and permissive interpretation (which risks consumer harm).
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.